BEAM logo

BEAM

Beam Therapeutics Inc.

$29.79
+$1.15(+4.02%)
57
Overall
60
Value
63
Tech
50
Quality
How is this score calculated?
Market Cap
$2.66B
Volume
1.41M
52W Range
$15.35 - $36.44
Target Price
$50.19
Order:

Income Statement

MetricTrendChart
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
2025
Dec
REVENUE
Total Revenue
$24.0K$51.8M$60.9M$377.7M$63.5M$139.7M
Total Revenue
$24.0K$51.8M$60.9M$377.7M$63.5M$139.7M
GROSS PROFIT
Gross Profit
$24.0K$51.8M$60.9M$377.7M$63.5M$139.7M
OPERATING EXPENSES
Operating Expenses
$132.8M$444.3M$399.4M$554.2M$479.1M$523.4M
Research & Development
$103.2M$387.1M$311.6M$437.4M$367.6M$409.6M
Research Expense
$103.2M$387.1M$311.6M$437.4M$367.6M$409.6M
Selling, General & Administrative
$29.6M$57.2M$87.8M$116.8M$111.5M$113.8M
General & Administrative Expenses
$29.6M$57.2M$87.8M$116.8M$111.5M$113.8M
Salaries & Wages
----$84.3M--$120.7M$94.2M
Depreciation & Amortization
$4.7M$7.2M$14.1M$20.0M$21.9M--
Depreciation & Amortization
$4.7M$7.2M$14.1M------
Other Operating Expenses
$9.3M$21.4M$22.9M------
OPERATING INCOME
Operating income
$-132.8M$-392.5M$-338.5M$-176.5M$-415.6M$-383.7M
EBITDA
$-128.0M$-385.0M$-271.5M$-101.6M$-354.8M$-57.7M
NON-OPERATING ITEMS
Intinc
--------$49.1M$43.7M
Net Non-Operating Interest Income/Expense
----$-15.3M$46.7M$49.1M$43.7M
Gain on Sale of Securities
$-62.9M$16.7M$44.1M$-11.1M$-11.8M$4.6M
Other Income/Expense
$61.8M$-21.8M$63.0M$11.1M$10.2M$-260.0M
Other Special Charges
$1.1M$5.1M$60.9M------
SPECIAL ITEMS
Special Income Charges
------$-6.5M----
PRE-TAX INCOME
EBIT
$-132.8M$-392.5M$-285.7M$-131.2M$-376.7M$-80.0M
Pre-Tax Income
$-194.6M$-370.6M$-260.2M$-131.2M$-376.7M$-80.0M
INCOME TAX
Tax Provision
----$3.4M$1.4M$39.0K--
NET INCOME
Net Income
$-194.6M$-370.6M$-289.1M$-132.5M$-376.7M$-80.0M
Net Income (Continuing Operations)
$-194.6M$-370.6M$-289.1M$-132.5M$-376.7M$-80.0M
Net Income (Discontinued Operations)
$-194.6M$-370.6M$-289.1M$-132.5M$-376.7M$-80.0M
Net Income (Common Stockholders)
$-195.9M$-370.6M$-289.1M$-132.5M$-376.7M$-80.0M
Normalized Income
----------$-79.4M
TOTALS
Total Expenses
$132.8M$444.3M$399.4M$554.2M$479.1M$523.4M
SHARE & EPS DATA
Average Shares Outstanding
$46.7M$64.2M$70.0M$77.2M$82.3M$98.9M
Average Shares Outstanding (Diluted)
--$64.2M$70.0M$77.2M$82.3M$98.9M
Shares Outstanding
$62.4M$68.7M$72.4M$81.7M$83.7M$101.9M
Basic EPS
$-4.19$-5.77$-4.13$-1.72$-4.58$-0.81
Basic EPS (Continuing Operations)
$-4.19$-5.77$-4.13$-1.72$-4.58$-0.81
Diluted EPS
$-4.19$-5.77$-4.13$-1.72$-4.58$-0.81
Diluted EPS (Continuing Operations)
--$-5.77$-4.13$-1.72$-4.58$-0.81
OTHER METRICS
Accretion On Preferred Stock
$1.3M----------
Earnings from equity interest
----$-25.5M----$255.1M
Earnings From Equity Interest Net Of Tax
----$-25.5M----$255.1M
Other Gand A
$29.6M$57.2M$87.8M$116.8M$111.5M$113.8M
Preferred Stock Dividends
$1.3M----------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2BEAM$29.79+4.0%1.41M
3
4
5
6

Get Beam Therapeutics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.